These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors. Tateo V, Manuzzi L, De Giglio A, Parisi C, Lamberti G, Campana D, Pantaleo MA. Int J Mol Sci; 2020 Nov 28; 21(23):. PubMed ID: 33260538 [Abstract] [Full Text] [Related]
6. Tropomyosin-related Kinase B Is Potentially a Biomarker of Prognosis and Therapeutic Target for Malignant Thymic Epithelial Tumors. Ozono K, Onishi H, Iwamoto N, Nakamura K, Miyoshi K, Nakamura M, Oda Y. Anticancer Res; 2022 Aug 28; 42(8):3779-3787. PubMed ID: 35896228 [Abstract] [Full Text] [Related]
7. Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations. Stachowicz-Stencel T, Synakiewicz A, Cornet M, Ferrari A, Garassino M, Masip JR, Julien R, Virgone C, Schneider DT, Brecht IB, Ben-Ami T, Bien E, Reguerre Y, Godzinski J, Bisogno G, Orbach D, Sarnacki S. Pediatr Blood Cancer; 2021 Jun 28; 68 Suppl 4():e29042. PubMed ID: 33881200 [Abstract] [Full Text] [Related]
8. [Thymic tumors]. Girard N, Merveilleux Du Vignaux C, Molina T, Besse B, Rythmic R. Rev Prat; 2017 Apr 28; 67(4):430-434. PubMed ID: 30512890 [Abstract] [Full Text] [Related]
9. Thymic epithelial tumor medical treatment: A narrative review. Huang Q, Zhu L, Liu Y, Zhang Y. Biochim Biophys Acta Rev Cancer; 2024 Sep 28; 1879(5):189167. PubMed ID: 39117091 [Abstract] [Full Text] [Related]
12. Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study. Molina TJ, Bluthgen MV, Chalabreysse L, de Montpréville VT, de Muret A, Dubois R, Hofman V, Lantuejoul S, le Naoures C, Mansuet-Lupo A, Parrens M, Piton N, Rouquette I, Secq V, Girard N, Marx A, Besse B. Eur J Cancer; 2021 Jan 28; 143():158-167. PubMed ID: 33316754 [Abstract] [Full Text] [Related]
14. Diagnostic and clinical significance of KIT(CD117) expression in thymic epithelial tumors in China. Song N, Chen G, Zhang P, Liu M, He WX, Jiang GN. Asian Pac J Cancer Prev; 2012 Apr 21; 13(6):2745-8. PubMed ID: 22938452 [Abstract] [Full Text] [Related]
15. Verification of the diagnostic strategy for anterior mediastinal tumors. Hakiri S, Kawaguchi K, Fukui T, Nakamura S, Ozeki N, Mori S, Goto M, Hashimoto K, Ito T, Yokoi K. Int J Clin Oncol; 2019 Apr 21; 24(4):385-393. PubMed ID: 30374687 [Abstract] [Full Text] [Related]
16. Treatments and outcomes of spinal metastasis from thymic epithelial tumors: 10-year experience with 15 patients in a single center. Jia Q, Yang J, Hu J, Liu T, Yang C, Wei H, Yang X, Xiao J. Eur Spine J; 2019 Jun 21; 28(6):1520-1528. PubMed ID: 31065810 [Abstract] [Full Text] [Related]
17. Fatal toxicity induced by anti-PD-1 immune checkpoint inhibitor in thymic epithelial tumor. Jing X, Zhu H, Li Y, Jia W, Zhai X, Li J, Yu J. Immunotherapy; 2022 Oct 21; 14(14):1097-1107. PubMed ID: 36093721 [Abstract] [Full Text] [Related]
18. Accuracy of pathologic diagnosis for thymic epithelial tumors: a brief report from an Italian reference Center. Galli G, Trama A, Abate-Daga L, Brambilla M, Garassino MC, Fabbri A. Lung Cancer; 2020 Aug 21; 146():66-69. PubMed ID: 32516667 [Abstract] [Full Text] [Related]